West Virginia Cannabis Sales

Among small-tier medical-only markets, West Virginia stands out for the severity of its price decline—down more than 21% year over year—while unit movement continues to climb. Two-year sales growth is nearly flat at negative 0.3%, and the 65-dispensary footprint has expanded only modestly. The state's compressed pricing trajectory more closely resembles mature recreational markets than the typical medical program, suggesting competitive pressure is intensifying even within a limited-license framework.

24-Month Trend

State	Sales	YoY
Locked State	$XX-XXM	XX.X%
Rhode Island	$5-10M	29.9%
Locked State	$XX-XXM	XX.X%
Delaware	$5-10M	25.6%
Locked State	$XX-XXM	XX.X%

Unlock The Full Table

Log in to unlock the full market comparison table and image export for this section.

Log in to unlockOpen app

Benchmarking

Market ComparisonAug 2026

Among small-tier medical-only markets, West Virginia stands out for the severity of its price decline—down more than 21% year over year—while unit movement continues to climb. Two-year sales growth is nearly flat at negative 0.3%, and the 65-dispensary footprint has expanded only modestly. The state's compressed pricing trajectory more closely resembles mature recreational markets than the typical medical program, suggesting competitive pressure is intensifying even within a limited-license framework.

24-Month Trend

State	Sales	YoY
Vermont	$10-15M	+2.6%
Rhode Island	$5-10M	+29.9%
West Virginia	$5-10M	+1.0%
Delaware	$5-10M	+25.6%
Georgia	$5-10M	+83.1%

Top performing dispensaries in West Virginia.

Store	City	Est. Sales
#1 Country Grown - Dunbar	Dunbar	$250-500K
#2 The Landing - Charleston	Charleston	$250-500K
#3 Greenlight Dispensary - Lewisburg	Lewisburg	<$250K
#4 The Landing - Bridgeport	Bridgeport	<$250K
#5 Trulieve - South Charleston	South Charleston	<$250K

Flower now commands nearly 60% of West Virginia's category mix after climbing 26.7% year over year, reclaiming share from vapes, which fell 17.1% to about 31% of the market. Concentrates collapsed by 59.5%, dropping to just 7.1% of sales, while oral products—edibles and tinctures—exploded 166.7% off a small base to reach 1.8%. ALTSOL is among the brands capitalizing on the flower-heavy shift. The concentration of spending in flower and the steep decline in concentrates suggest West Virginia patients are gravitating toward familiar, lower-cost formats as prices fall across the board.

Category	Sales	Avg Price	YoY
#1Flower	$2.5-5M	$40.19	3.6%
#2Vapes	$2.5-5M	$39.71	17.4%
#3Concentrates	$250-500K	$38.78	21.8%
#4Oral	<$250K	$39.17	3.3%
#5Accessories	<$250K	$18.42	9.7%
#6Topicals	<$250K	$33.15	56.7%